Arterra Bioscience (ARBS) Q2 2025 TU earnings summary

Executive summary

• Revenue as of June 30, 2025, reached approximately €2.6 million, up 12.8% year-over-year compared to the same period in 2024.

• Sales of cosmetic raw materials totaled about €2.2 million, marking a 15% increase year-over-year.

• Service revenues were €370,440, a slight increase of 1.17% from the previous year.

• Management remains confident in achieving set targets, supported by strong order intake in recent months.

Financial highlights

• Total revenue for the first half of 2025 was €2,572,170, compared to €2,280,620 in the first half of 2024.

• Cosmetic raw material sales contributed the majority of revenue growth, rising from €1,914,470 to €2,201,730.

• Service revenues showed marginal growth, from €366,150 to €370,440.

Outlook and guidance

• Management expresses optimism for meeting programmed objectives, citing robust order acquisition.